INT160994

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.20
First Reported 2007
Last Reported 2011
Negated 0
Speculated 0
Reported most in Body
Documents 9
Total Number 10
Disease Relevance 4.83
Pain Relevance 3.71

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

unfolded protein binding (St13) protein folding (St13) cytosol (St13)
protein complex (St13) cytoplasm (St13)
Anatomy Link Frequency
DA neurons 2
neurons 1
striatum 1
CPu 1
St13 (Mus musculus)
Pain Link Frequency Relevance Heat
Dopamine 210 100.00 Very High Very High Very High
Antinociceptive 5 99.98 Very High Very High Very High
Neurotransmitter 2 99.64 Very High Very High Very High
Oxycodone 8 99.44 Very High Very High Very High
narcan 1 99.26 Very High Very High Very High
antagonist 12 99.08 Very High Very High Very High
Enkephalin 4 99.00 Very High Very High Very High
Opioid 1 98.86 Very High Very High Very High
antinociception 8 98.24 Very High Very High Very High
monoamine 34 94.48 High High
Disease Link Frequency Relevance Heat
Disease 301 99.50 Very High Very High Very High
Parkinson's Disease 108 99.26 Very High Very High Very High
Parkinsonian Disorders 8 97.92 Very High Very High Very High
Hypokinesia 8 97.20 Very High Very High Very High
Targeted Disruption 71 95.84 Very High Very High Very High
Muscle Rigidity 10 95.56 Very High Very High Very High
Tremor 4 94.80 High High
Loss Of Sense Of Smell 3 91.40 High High
Toxicity 29 82.64 Quite High
Depression 5 73.84 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Moreover, starting after three MPTPp injections, we observed a gradual decline of TH-positive cells in the SNc, and a gradual raise of enkephalin mRNA in the CPu.
Negative_regulation (decline) of SNc in CPu associated with enkephalin
1) Confidence 0.20 Published 2009 Journal Neurotox Res Section Abstract Doc Link 19526289 Disease Relevance 0.56 Pain Relevance 0.40
Opioid-antagonist naloxone, completely blocked antinociceptive effect of DAMGO, SNC80, U50,488H or oxycodone and potentiation of antinociception by BMS182874.
Negative_regulation (effect) of SNC80 associated with antinociception, oxycodone, antagonist, narcan, antinociceptive and opioid
2) Confidence 0.10 Published 2010 Journal Eur. J. Pharmacol. Section Abstract Doc Link 20303944 Disease Relevance 0 Pain Relevance 2.28
This reduction in TH-Ser(P)-19 in WT-Syn- and S129A-Syn-transduced SNc suggested that TH activity might also be reduced in a-Syn lentivirally transduced mice.
Negative_regulation (reduction) of SNc
3) Confidence 0.06 Published 2010 Journal The Journal of Biological Chemistry Section Body Doc Link PMC2878529 Disease Relevance 0 Pain Relevance 0.12
Silencing of the Pink1 gene expression did not induce Parkinson's disease phenotypes, including a loss of the dopaminergic neurons in the SNc and the neurotransmitter dopamine in the striatum.
Negative_regulation (loss) of SNc in striatum associated with dopamine, neurotransmitter and disease
4) Confidence 0.04 Published 2007 Journal International Journal of Biological Sciences Section Body Doc Link PMC1820878 Disease Relevance 0.51 Pain Relevance 0.10
Neuropathological examination of MPTP-treated mice revealed a progressive decrease in the number of TH-positive neurons in the SNc as early as 3 days after the MPTP treatment as compared to the saline-treated mouse brains.
Negative_regulation (decrease) of SNc in neurons associated with parkinson's disease
5) Confidence 0.03 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2675062 Disease Relevance 0.92 Pain Relevance 0
Indeed, systemic exposure to paraquat provoked a dose-dependent loss of DA neurons in the SNc [8, 38], coupled with a reduction in the density of striatal DA fibres expressing tyrosine hydroxylase, the rate-limiting enzyme in DA synthesis [39].
Negative_regulation (loss) of SNc in DA neurons associated with dopamine
6) Confidence 0.02 Published 2011 Journal Parkinson's Disease Section Body Doc Link PMC3018622 Disease Relevance 1.00 Pain Relevance 0.29
60% SNc DA neuron loss, comprises a constellation of well-defined motor symptoms, including bradykinesia, hypokinesia (or akinesia), cogwheel rigidity, resting tremor, and postural instability [1].
Negative_regulation (loss) of SNc in DA neuron associated with tremor, dopamine, hypokinesia and muscle rigidity
7) Confidence 0.02 Published 2011 Journal Parkinson's Disease Section Body Doc Link PMC3018622 Disease Relevance 1.48 Pain Relevance 0.37
Critically, the loss of TH+ cells in the SNc was mirrored by an equivalent reduction in NeuN+ cells in the lesioned SNc in vehicle-treated animals (67.43 ± 1.15% [95% CI: 64.74%–69.95%]).
Negative_regulation (reduction) of SNc
8) Confidence 0.01 Published 2010 Journal Parkinson's Disease Section Body Doc Link PMC2951138 Disease Relevance 0.06 Pain Relevance 0.03
Critically, the loss of TH+ cells in the SNc was mirrored by an equivalent reduction in NeuN+ cells in the lesioned SNc in vehicle-treated animals (67.43 ± 1.15% [95% CI: 64.74%–69.95%]).
Negative_regulation (loss) of SNc
9) Confidence 0.01 Published 2010 Journal Parkinson's Disease Section Body Doc Link PMC2951138 Disease Relevance 0.06 Pain Relevance 0
In the current study we also observed that the neuroprotective effects of 2R,4R-APDC were associated with a qualitative decrease in microglial markers in the SNc.
Negative_regulation (decrease) of SNc
10) Confidence 0.01 Published 2010 Journal Parkinson's Disease Section Body Doc Link PMC2951138 Disease Relevance 0.25 Pain Relevance 0.14

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox